About JHP Pharmaceuticals, LLC
 JHP, headquartered in New Jersey, is a recently formed company founded by Peter Jenkins and Stuart Hinchen, previously senior executives with the leading global specialty injectables company, Mayne Pharma Limited which was recently acquired by Hospira, Inc. JHP plans to become a significant marketer of hospital and clinic based pharmaceuticals in the US, as well as a quality contract manufacturer of aseptically manufactured pharmaceuticals with an emphasis on biologic based products. JHP is a wholly-owned subsidiary of JHP Holdings, LLC, a private company whose equity owners are Morgan Stanley Principal Investments, Peter Jenkins and Stuart Hinchen.
This company has nothing to do with Immune or sub. Only thing in common is that it’s private and it loves to play musical chairs.
